Log in
Enquire now
Homology Medicines

Homology Medicines

A genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases.

OverviewStructured DataIssuesContributors

Contents

homologymedicines.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Genetic engineering
Genetic engineering
Alternative medicine
Alternative medicine
Genetics
Genetics
Healthcare
Healthcare
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
...
Location
United States
United States
Bedford
Bedford
Bedford, Massachusetts
Bedford, Massachusetts
0
B2X
B2B
B2B
CEO
Arthur Tzianabos
Arthur Tzianabos
0
Founder
Laura Smith
Laura Smith
Pitchbook URL
pitchbook.com/profiles...150985-27
Legal Name
Homology Medicines, Inc.
Legal classification
Corporation
Corporation
Incorporation (business)
Incorporation (business)
Date Incorporated
June 3, 2015
Number of Employees (Ranges)
51 – 200
Email Address
info@homologymedicines.com0
Full Address
1 Patriots Park Bedford, MA 017300
45 Wiggins Avenue Bedford, MA 01730 United States
CIK Number
1,661,9980
Place of Incorporation
Delaware
Delaware
0
Investors
5AM Ventures
5AM Ventures
Vida Ventures
Vida Ventures
ARCH Venture Partners
ARCH Venture Partners
Deerfield Management
Deerfield Management
Maverick Ventures
Maverick Ventures
Novartis
Novartis
Pfizer
Pfizer
Rock Springs Capital
Rock Springs Capital
...
IRS Number
473,468,1540
Founded Date
2015
Total Funding Amount (USD)
210,068,876
Latest Funding Round Date
November 9, 2020
Competitors
Helix
Helix
Kaleido Biosciences
Kaleido Biosciences
Stock Symbol
FIXX0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
Richard Gregory
Richard Gregory
0
‌
Steven Gillis
0
‌
Jeff Poulton
0
Mary Thistle
Mary Thistle
0
‌
Alise Reicin
0
‌
Matthew R. Patterson
0
‌
Kush Parmar
0
Arthur Tzianabos
Arthur Tzianabos
0
CFO
‌
Brad Smith
0
Latest Funding Type
Series B
Series B
NAICS Code
325,4120
Patents Assigned (Count)
1
Country
United States
United States
0

Other attributes

Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
FIXX

Homology Medicines is a genetic medicines company in Massachusetts that focuses on patients suffering from rare genetic diseases. Founded 2015 in Lexington, Massachusetts, United States by Laura Smith and Saswati Chatterjee, Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. The company has a suite of 15 AAVHSC patents, including a proprietary gene editing and gene therapy platform for rare diseases.

The company has developed a novel set of adeno-associated virus vectors derived from human hematopoietic stem cells (AAVHSCs) that are designed to precisely and efficiently deliver genetic medicines in vivo either through gene therapy or by harnessing the body’s natural DNA repair process of homologous recombination through nuclease-free gene editing.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Homology Medicines

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.